EcoDrugPlus

Glutamate Receptor, Ionotropic, Kainate 1

Ensembl ID : ENSMSIG00000012264
Gene Symbol: GRIK1
1 Cross references
317 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 2 (Beta 2)

Ensembl ID : ENSMSIG00000023165
Gene Symbol: GRIK2
1 Cross references
346 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 3

Ensembl ID : ENSMSIG00000015725
Gene Symbol: GRIK3
1 Cross references
271 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 5 (Gamma 2)

Ensembl ID : ENSMSIG00000010580
Gene Symbol: GRIK5
1 Cross references
317 Possible Orthologues:

Glutamate Receptor, Metabotropic 2

Ensembl ID : ENSMSIG00000010149
Gene Symbol: GRM2
1 Cross references
291 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSMSIG00000009374
Gene Symbol: GRM3
1 Cross references
230 Possible Orthologues:

Glutamate Receptor, Metabotropic 4

Ensembl ID : ENSMSIG00000005245
Gene Symbol: GRM4
1 Cross references
288 Possible Orthologues:

Glutamate Receptor, Metabotropic 5

Ensembl ID : ENSMSIG00000001662
Gene Symbol: GRM5
1 Cross references
287 Possible Orthologues:

Glutaminase

Ensembl ID : ENSMSIG00000003887
Gene Symbol: GLS
1 Cross references
320 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSMSIG00000011808
Gene Symbol: GSK3A
1 Cross references
275 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSMSIG00000018514
Gene Symbol: GSK3B
1 Cross references
256 Possible Orthologues:

Glycoprotein 6 (Platelet)

Ensembl ID : ENSMSIG00000003816
Gene Symbol: GP6
1 Cross references
150 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).